Document Detail


Treatment of severe hypertension with intravenous labetalol.
MedLine Citation:
PMID:  7116758     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The effectiveness of repeated intravenous injections of labetalol in reducing blood pressure (BP) was evaluated in patients with severe hypertension. The subjects were 10 patients who were 29 to 61 yr old and who had diastolic blood pressure (DBP) of 125 mm Hg or higher. Repeated injections titrated from 20 to 80 mg were given at 15-min intervals until there was a reduction in DBP of 30 mm Hg or until 300 mg had been administered. The average reduction of BP ranged from 201 +/- 5/132 +/- 1 to 157 +/- 6/108 +/- 4 mm Hg (mean +/- SEM). Four patients responded with a reduction in DBP of 30 mm Hg or more with total doses of 60 to 220 mg. Of the remaining six who received the full dose, in four there was a 20 to 29 mm Hg reduction in DBP, in one there was a 10 mm Hg fall, and in one there was no reduction. There was a positive correlation between age and response to intravenous labetalol. No severe side effects were encountered. Intravenous labetalol is useful and well tolerated in patients with severe hypertension.
Authors:
V Papademetriou; A V Notargiacomo; I M Khatri; E D Freis
Related Documents :
22919998 - Analysis of blood pressure changes in patients undergoing total hip or knee replacement...
16157788 - Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, ...
10950398 - Lowering of blood pressure and predictors of response in patients with left ventricular...
9017758 - Chronobiometric assessment of autogenic training effects upon blood pressure and heart ...
2021198 - Sodium nitroprusside infusion does not dilate cerebral resistance vessels during hypoth...
18407268 - Mask adaptor--a novel method of positive pressure ventilation during propofol deep seda...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Clinical pharmacology and therapeutics     Volume:  32     ISSN:  0009-9236     ISO Abbreviation:  Clin. Pharmacol. Ther.     Publication Date:  1982 Oct 
Date Detail:
Created Date:  1982-12-03     Completed Date:  1982-12-03     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0372741     Medline TA:  Clin Pharmacol Ther     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  431-5     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aging
Dose-Response Relationship, Drug
Ethanolamines / therapeutic use*
Heart Rate / drug effects
Humans
Hypertension / drug therapy*
Injections, Intravenous
Labetalol / therapeutic use*
Middle Aged
Chemical
Reg. No./Substance:
0/Ethanolamines; 36894-69-6/Labetalol

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Kinetics of the digoxin-aspirin combination.
Next Document:  Drug-plasma protein binding in Kutchin Athapaskan indians.